Shuttle Pharmaceuticals (SHPH) Competitors $0.87 -0.03 (-2.97%) (As of 02:09 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends SHPH vs. WENA, SNSE, NKGN, AWH, TLPH, TSBX, CDT, INDP, PHXM, and KPRXShould you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include ANEW Medical (WENA), Sensei Biotherapeutics (SNSE), NKGen Biotech (NKGN), Aspira Women's Health (AWH), Talphera (TLPH), Turnstone Biologics (TSBX), Conduit Pharmaceuticals (CDT), Indaptus Therapeutics (INDP), PHAXIAM Therapeutics (PHXM), and Kiora Pharmaceuticals (KPRX). These companies are all part of the "pharmaceutical products" industry. Shuttle Pharmaceuticals vs. ANEW Medical Sensei Biotherapeutics NKGen Biotech Aspira Women's Health Talphera Turnstone Biologics Conduit Pharmaceuticals Indaptus Therapeutics PHAXIAM Therapeutics Kiora Pharmaceuticals Shuttle Pharmaceuticals (NASDAQ:SHPH) and ANEW Medical (NASDAQ:WENA) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations, media sentiment and community ranking. Do insiders & institutionals believe in SHPH or WENA? 4.6% of Shuttle Pharmaceuticals shares are owned by institutional investors. Comparatively, 20.1% of ANEW Medical shares are owned by institutional investors. 39.6% of Shuttle Pharmaceuticals shares are owned by insiders. Comparatively, 2.0% of ANEW Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has better valuation and earnings, SHPH or WENA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShuttle PharmaceuticalsN/AN/A-$6.59M-$4.15-0.21ANEW MedicalN/AN/AN/AN/AN/A Is SHPH or WENA more profitable? ANEW Medical's return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Shuttle PharmaceuticalsN/A -583.02% -258.92% ANEW Medical N/A N/A N/A Does the MarketBeat Community believe in SHPH or WENA? Shuttle Pharmaceuticals and ANEW Medical both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformShuttle PharmaceuticalsN/AN/AANEW MedicalN/AN/A Does the media prefer SHPH or WENA? In the previous week, Shuttle Pharmaceuticals had 1 more articles in the media than ANEW Medical. MarketBeat recorded 1 mentions for Shuttle Pharmaceuticals and 0 mentions for ANEW Medical. Shuttle Pharmaceuticals' average media sentiment score of 0.66 beat ANEW Medical's score of 0.00 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Shuttle Pharmaceuticals Positive ANEW Medical Neutral SummaryShuttle Pharmaceuticals and ANEW Medical tied by winning 3 of the 6 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHPH vs. The Competition Export to ExcelMetricShuttle PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.19M$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E Ratio-0.215.5095.1214.22Price / SalesN/A375.021,217.3088.42Price / CashN/A52.5939.4936.27Price / Book-2.4210.276.976.37Net Income-$6.59M$153.22M$118.73M$225.56M7 Day Performance-18.57%-1.19%-1.22%-0.02%1 Month Performance-32.46%-6.71%-3.07%2.04%1 Year PerformanceN/A32.39%32.52%28.00% Shuttle Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHPHShuttle Pharmaceuticals0.5243 of 5 stars$0.87-3.0%N/AN/A$3.19MN/A-0.215WENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap UpSNSESensei Biotherapeutics4.8056 of 5 stars$0.48-2.8%$4.33+795.5%-20.0%$12.17MN/A0.0040News CoverageNKGNNKGen BiotechN/A$0.34+7.9%N/A-89.1%$11.94M$80,000.00-0.06N/AGap UpHigh Trading VolumeAWHAspira Women's Health1.6792 of 5 stars$0.74+1.4%$4.40+494.6%-78.5%$11.88M$9.15M-0.64110Analyst ForecastTLPHTalphera2.6915 of 5 stars$0.69-1.9%$4.50+549.3%N/A$11.80M$650,000.000.0019Gap UpTSBXTurnstone Biologics3.2023 of 5 stars$0.48+4.4%$2.13+342.7%-84.8%$11.10M$19.31M0.0082CDTConduit PharmaceuticalsN/A$0.11+22.0%N/A-92.8%$10.81MN/A0.003News CoverageGap UpHigh Trading VolumeINDPIndaptus Therapeutics2.7304 of 5 stars$1.05-1.4%$8.50+713.4%-48.7%$10.66MN/A0.006PHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049KPRXKiora Pharmaceuticals2.9909 of 5 stars$3.38-1.2%$10.00+195.9%-32.4%$10.14MN/A0.0010 Related Companies and Tools Related Companies WENA Alternatives SNSE Alternatives NKGN Alternatives AWH Alternatives TLPH Alternatives TSBX Alternatives CDT Alternatives INDP Alternatives PHXM Alternatives KPRX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SHPH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.